Health TrialsbyHealthPanel

Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer

ConditionColorectal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorTaichung Veterans General Hospital

About this trial

This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 20 years and older.

Patients who have been given a diagnosis of colorectal cancer.

Patients had previously initiated anti-cancer therapies between January 1, 2020, and Apr 30, 2024.

Disqualifiers

None

Trial population

Colorectal Cancer

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

250 Participants
are grouped into 2 trial groups
Group A: Cancer treatment with immunomodulator
Group B: Cancer treatment without immunomodulator

Trial outcomes

Primary outcomes

1

Overall survival

Time frame
From the initial treatment until April 2024

Secondary outcomes

1

Progress free survival

Time frame
From the initial treatment until April 2024
2

Tumor response

Time frame
From the initial treatment until April 2024

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Taichung Veterans General Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now